These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8402676

  • 1. Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
    Lowis SP, Pearson AD, Newell DR, Cole M.
    Cancer Res; 1993 Oct 15; 53(20):4881-9. PubMed ID: 8402676
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetics of etoposide short-term infusions within the scope of the GPOH therapy protocol].
    Boos J, Real E, Schulze-Westhoff P, Pröbsting B, Wolff J, Jürgens H.
    Klin Padiatr; 1993 Oct 15; 205(4):288-94. PubMed ID: 8377449
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K, Gervais A, Aikin A, Egorin M, Balis FM.
    Cancer Chemother Pharmacol; 2004 Sep 15; 54(3):206-12. PubMed ID: 15156345
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and pharmacodynamics of 21-day continuous oral etoposide in pediatric patients with solid tumors.
    Sonnichsen DS, Ribeiro RC, Luo X, Mathew P, Relling MV.
    Clin Pharmacol Ther; 1995 Jul 15; 58(1):99-107. PubMed ID: 7628187
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the variability of etoposide pharmacokinetics in children.
    Boos J, Real E, Schulze-Westhof, Wolff J, Euting T, Jürgens H.
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov 15; 30(11):495-7. PubMed ID: 1490803
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetic aspects of oral administration of etoposide].
    Tillmann B, Krümpelmann S, Würthwein G, Wagner A, Schulze-Westhoff P, Hempel G, Jürgens H, Boos J.
    Klin Padiatr; 1998 Nov 15; 210(4):159-64. PubMed ID: 9743946
    [Abstract] [Full Text] [Related]

  • 7. Etoposide pharmacokinetics in children treated for acute myeloid leukemia.
    Palle J, Frost BM, Gustafsson G, Hellebostad M, Kanerva J, Liliemark E, Schmiegelow K, Lönnerholm G, Nordic Society of Paediatric Haematology and Oncology.
    Anticancer Drugs; 2006 Oct 15; 17(9):1087-94. PubMed ID: 17001183
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
    Zucchetti M, Pagani O, Torri V, Sessa C, D'Incalci M, De Fusco M, de Jong J, Gentili D, Martinelli G, Tinazzi A.
    Clin Cancer Res; 1995 Dec 15; 1(12):1517-24. PubMed ID: 9815952
    [Abstract] [Full Text] [Related]

  • 9. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D, Boddy A, Thomas H, Lind M, Newell D, Calvert AH, Robson L, Brampton M, Abrahamsen D, Winograd B.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM, Blakley RL, Santana VM, Crom WR.
    Cancer Res; 1994 Mar 01; 54(5):1235-9. PubMed ID: 7906999
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetic study of etoposide in aged patient with non Hodgkin lymphoma receiving hemodialysis].
    Miyaoka K, Matsubara T, Matsumoto T, Kanda C.
    Gan To Kagaku Ryoho; 1991 Oct 01; 18(13):2325-8. PubMed ID: 1929451
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K.
    Cancer Chemother Pharmacol; 2003 Jun 01; 51(6):465-73. PubMed ID: 12698270
    [Abstract] [Full Text] [Related]

  • 13. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    You B, Tranchand B, Girard P, Falandry C, Ribba B, Chabaud S, Souquet PJ, Court-Fortune I, Trillet-Lenoir V, Fournel C, Tod M, Freyer G.
    Lung Cancer; 2008 Nov 01; 62(2):261-72. PubMed ID: 18442869
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
    Kroschinsky FP, Friedrichsen K, Mueller J, Pursche S, Haenel M, Prondzinsky R, Ehninger G, Schleyer E.
    Cancer Chemother Pharmacol; 2008 Apr 01; 61(5):785-90. PubMed ID: 17579865
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation scheme.
    Graham MA, Newell DR, Foster BJ, Gumbrell LA, Jenns KE, Calvert AH.
    Cancer Res; 1992 Feb 01; 52(3):603-9. PubMed ID: 1732048
    [Abstract] [Full Text] [Related]

  • 16. Low dose--high dose: what is the right dose? Pharmacokinetic modeling of etoposide.
    Würthwein G, Boos J.
    Cancer Chemother Pharmacol; 2002 Apr 01; 49(4):303-8. PubMed ID: 11914910
    [Abstract] [Full Text] [Related]

  • 17. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M, Chamouard V, Bressolle F, Boulieu R.
    Ther Drug Monit; 2007 Feb 01; 29(1):20-6. PubMed ID: 17304146
    [Abstract] [Full Text] [Related]

  • 18. What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 days.
    van der Gaast A, Vlastuin M, Kok TC, Splinter TA.
    Semin Oncol; 1992 Dec 01; 19(6 Suppl 14):8-12. PubMed ID: 1488657
    [Abstract] [Full Text] [Related]

  • 19. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring.
    Vassal G, Michel G, Espérou H, Gentet JC, Valteau-Couanet D, Doz F, Mechinaud F, Galambrun C, Neven B, Zouabi H, Nguyen L, Puozzo C.
    Cancer Chemother Pharmacol; 2008 Jan 01; 61(1):113-23. PubMed ID: 17393167
    [Abstract] [Full Text] [Related]

  • 20. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
    Plard C, Bressolle F, Fakhoury M, Zhang D, Yacouben K, Rieutord A, Jacqz-Aigrain E.
    Cancer Chemother Pharmacol; 2007 Sep 01; 60(4):609-20. PubMed ID: 17195068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.